Merck plans to acquire Prometheus for $10.8 billion in an all-cash deal. The deal will add Prometheus' lead candidate, immunology drug PRA023, to Merck's pipeline. The magnitude of Prometheus' massive ...

Check out to venture into the Digital Wasteland and find out what business you can launch with GoDaddy Airo. And don't miss Season Two of Fallout, streaming exclusively on Prime Video! @godaddy ...

Shares of Prometheus Biosciences soared 70% in premarket trading on Monday after Merck & Co. announced that it would acquire the company in a $10.8 billion deal. The deal, announced Sunday, gives ...

Mr. Paoni brings a wealth of experience around scaling large organizations. "DJ joins our board at an inflection point here at Prometheus Group," said Eric Huang, CEO of Prometheus Group. "I believe ...